STEVEN NICHOLS: Open Payments
NPI 1790055366 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 82 payments from 16 companies in 2025. Trend: 2023 $42 · 2024 $398 · 2025 $1,628
Food & beverage: $1,628
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $439 |
| Amgen Inc. | 19 | $315 |
| PFIZER INC. | 15 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $108 |
| Kestra Medical Technology Services, Inc. | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Merck Sharp & Dohme LLC | 2 | $57 |
| GlaxoSmithKline, LLC. | 2 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $52 |
| BridgeBio Pharma, Inc. | 2 | $51 |
Products named: LEQVIO, Repatha, ELIQUIS, JARDIANCE, Assure WCD, VERQUVO, SHINGRIX, ONPATTRO.
Industry payments across PA — which companies pay providers there.
